Tagged with GW Pharma

Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for Cannabinoid Research
GW Pharma’s CBD Drug Profits Soar in 2nd Quarter 2019
Five Emerging Trends in Medical Cannabis
Company Profile: GW Pharmaceuticals
10 Global CEOs PharmaBoardroom Interviewed in 2018
Pioneering cannabis for children’s treatments
Geoffrey Guy, Chairman, GW Pharma
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here